Jobs
-
Berkley Pharma & Life Science are currently seeking a Blending & Micronisation Manager for our client a Global pharmaceutical company based in Dublin. Ref: 5040176 Role/Opportunity: • An experienced Process Development Scientist or Pharmaceutical Engineer… Read more . . .
-
We are currently seeking a Device Senior Scientist for our Global Pharmaceutical client based in the Dublin area, due to major growth at the company they are looking to add to their team. Ref: 5040182… Read more . . .
-
Our client a global pharmaceutical company are currently seeking an Assembly & Packaging Manager to join their organisation. Ref: 5040178 Role/Opportunity: • Device assembly and/or packaging engineer responsible for leading and managing the final drug-device… Read more . . .
-
Berkley Pharma & Life Science are currently seeking a QA Manager/QP for our client a Global pharmaceutical company based in Dublin. Ref: 5040183 Role/Opportunity: • To manage and lead the Pilot Plant site Quality Assurance… Read more . . .
-
Berkley Pharma & Life Science are currently seeking an Equipment Senior Scientist for our client, a leading pharmaceutical company based in Dublin. Ref: 5040180 Role/Opportunity: • Seeking an experienced Manufacturing Equipment specialist with a good… Read more . . .
-
Consort Medical has announced record revenue and profits for the year ending April 30, 2012, including a 12% increase in revenue for its Bespak division, which manufactures metered dose inhaler valves and actuators as well… Read more . . .
-
Contract particle characterization specialist Gateway Analytical has announced that it will host the 2012 Inhalation and Nasal Technology Focus Group (INTFG) Annual Fall Symposium on September 7, 2012 at the Pittsburgh North Marriott in Cranberry,… Read more . . .
-
Submit poster abstracts by August 19, 2012 at the INTFG submission site. Submissions on any inhalation or nasal drug technology topic are welcome. More information. Read more . . .
-
Savara Pharmaceuticals has announced positive top-line results from a Phase 1 study of its AeroVanc inhaled dry powder formulation of vancomycin for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in patients with cystic fibrosis.… Read more . . .
-
Entries submitted to several student inhaler and medical device design contests over the past year envision some radical changes in inhaler design. These concepts, created by students who range in age from primary school through… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
October 21-October 22: MVIC Symposium, Lund, Sweden
November 10-November 11: Rescon Europe 2026, Porto, Portugal
December 9-December 11: DDL 2026, Edinburgh, Scotland